Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers

被引：0
|
作者：
Claudia Marchetti
Francesca De Felice
Innocenza Palaia
Giorgia Perniola
Angela Musella
Daniela Musio
Ludovico Muzii
Vincenzo Tombolini
Pierluigi Benedetti Panici
机构：
[1] University of Rome 2“Sapienza”,Department of Gynecological and Obstetrical Sciences and Urological Sciences
[2] Policlinico Umberto I “Sapienza” University of Rome,Department of Radiotherapy
来源：
BMC Women's Health | / 14卷
关键词：
Risk-reducing salpingo-oophorectomy; Prophylactic; BRCA; Ovarian cancer; Cause; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation
    Dongwon Kim
    Eunyoung Kang
    Euijun Hwang
    Young Sun
    Yoonsun Hwang
    Cha Kyong Yom
    Kidong Kim
    Jae Hong No
    Yong-Beom Kim
    Sung-Won Kim
    Familial Cancer, 2013, 12 : 621 - 628
  • [42] Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation
    Kim, Dongwon
    Kang, Eunyoung
    Hwang, Euijun
    Sun, Young
    Hwang, Yoonsun
    Yom, Cha Kyong
    Kim, Kidong
    No, Jae Hong
    Kim, Yong-Beom
    Kim, Sung-Won
    FAMILIAL CANCER, 2013, 12 (04) : 621 - 628
  • [43] Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact
    Andrea, Rosati
    Camilla, Fedele
    Anna, Fagotti
    Letizia, Lafuenti
    Alessandro, Gioe
    Rosaria, Chieffo Daniela Pia
    Giuseppe, Vizzielli
    Giovanni, D'Ippolito
    Vanda, Salutari
    Ida, Paris
    Claudia, Marchetti
    Giovanni, Scambia
    Salvatore, Gueli Alletti
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 273 : 1 - 6
  • [44] Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy
    C. A. Gabriel
    J. Tigges-Cardwell
    J. Stopfer
    J. Erlichman
    K. Nathanson
    S. M. Domchek
    Familial Cancer, 2009, 8 : 23 - 28
  • [45] Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience
    Harmsen, M. G.
    Arts-de Jong, M.
    Horstik, K.
    Manders, P.
    Massuger, L. F. A. G.
    Hermens, R. P. M. G.
    Hoogerbrugge, N.
    Woldringh, G. H.
    de Hullu, J. A.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 113 - 119
  • [46] Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy
    Gabriel, C. A.
    Tigges-Cardwell, J.
    Stopfer, J.
    Erlichman, J.
    Nathanson, K.
    Domchek, S. M.
    FAMILIAL CANCER, 2009, 8 (01) : 23 - 28
  • [47] Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
    Conduit, Ciara
    Milne, Roger L.
    Friedlander, Michael L.
    Phillips, Kelly-Anne
    CANCER PREVENTION RESEARCH, 2021, 14 (11) : 983 - 993
  • [48] Quality of life after risk-reducing salpingo-oophorectomy in women with a pathogenic BRCA variant
    Zilski, Nicole
    Speiser, Dorothee
    Bartley, Julia
    Roehle, Robert
    Blohmer, Jens-Uwe
    Keilholz, Ulrich
    Goerling, Ute
    JOURNAL OF SEXUAL MEDICINE, 2023, 21 (01) : 33 - 39
  • [49] Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations
    Smith, Maria J.
    Gerber, Deanna
    Olsen, Anne
    Khouri, Olivia R.
    Wang, Yuyan
    Liu, Mengling
    Smith, Julia
    Pothuri, Bhavana
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 225 (05)
  • [50] The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in BRCA Mutation Carriers and the Role of Physician-Patient Communication
    Alves-Nogueira, Ana C.
    Melo, Daniela
    Carona, Carlos
    Figueiredo-Dias, Margarida
    CURRENT ONCOLOGY, 2023, 30 (02) : 2429 - 2440
12345